Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/29145

Title: Baseline characteristics of patients enrolled in LEMQoL, a study assessing health-related quality of life in RRMS patients treated with alemtuzumab in a real-world clinical setting
Authors: Van Wijmeersch, Bart
Patti, F.
Hobart, J.
Kizlaitiene, R.
Vanderdonckt, P.
Shor, S.
Andreasen, A. K.
Uitdehaag, B. M.
Issue Date: 2019
Publisher: WILEY
Citation: EUROPEAN JOURNAL OF NEUROLOGY, 26, p. 866-866
Notes: [Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium. [Patti, F.] Univ Catania, Teaching Hosp Policlin, Multiple Sclerosis Ctr, Catania, Italy. [Hobart, J.] Plymouth Univ, Peninsula Sch Med, Plymouth, Devon, England. [Hobart, J.] Plymouth Univ, Peninsula Sch Dent, Plymouth, Devon, England. [Kizlaitiene, R.] Vilnius Univ, Hosp Santariskiu Clin, Ctr Neurol, Clin Neurol & Neurosurg,Fac Med, Vilnius, Lithuania. [Vanderdonckt, P.] AZ Groeninge, Kortrijk, Belgium. [Shor, S.; Andreasen, A. K.] Sanofi, Amsterdam, Netherlands. [Uitdehaag, B. M.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands.
URI: http://hdl.handle.net/1942/29145
ISI #: 000474481004025
ISSN: 1351-5101
Category: M
Type: Journal Contribution
Appears in Collections: Research publications

Files in This Item:

There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.